RXRX insider sale notice: 100,000 Class A shares

The issuer submitted a Form 144 disclosing a prospective sale of 100,000 Class A shares tied to restricted stock vesting dated 05/15/2025.

Rhea-AI Filing Summary

The issuer submitted a Form 144 disclosing a prospective sale of 100,000 Class A shares tied to restricted stock vesting dated 05/15/2025. The filing lists multiple recent dispositions by Christopher C. Gibson, including a reported 340,440 shares sold for $1,089,541.29 through several trades between 04/07/2026 and 06/18/2026.

Insights

Securities Attorney

Form 144 notice for proposed sale of vested restricted shares.

The filing documents a proposed resale of 100,000 Class A shares resulting from restricted stock vesting on 05/15/2025. It also records multiple reported dispositions by an individual, including a cumulative row showing 340,440 shares for $1,089,541.29.

Qualification and timing: the notice is informational and registers an intent to sell under Section 144 rules; actual sale amounts, timing, and method depend on holder actions and compliance with transfer restrictions and broker procedures.

Capital Markets Analyst

Transactions show recurring insider sales across April–June 2026.

The excerpt lists sequential dispositions of 40,000 shares on multiple dates and a larger cumulative entry of 340,440 shares. These entries reflect reported sales activity, with dollar amounts shown per trade in the excerpt.

Market effect: this notice is administrative under resale rules; the excerpt does not state aggregate outstanding float or whether these sales will be block trades or open‑market transactions.

Key Figures

Proposed resale: 100,000 shares Reported cumulative dispositions: 340,440 shares Proceeds shown (aggregate row): $1,089,541.29 +1 more

4 metrics

Proposed resale 100,000 shares Restricted stock vesting on 05/15/2025

Reported cumulative dispositions 340,440 shares Aggregate row in excerpt covering trades through 06/18/2026

Proceeds shown (aggregate row) $1,089,541.29 Associated with the 340,440 shares reported on 06/18/2026

Individual trades (sample) 40,000 shares Multiple trade entries on 04/07/2026, 04/22/2026, 05/07/2026, 05/22/2026, 06/05/2026

Key Terms

Form 144, Restricted Stock Vesting, Issuer, Compensation

4 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Class A | 05/15/2025 | Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Issuer regulatory

"Restricted Stock Vesting | Issuer | 100000"

Compensation financial

"100000 | 05/15/2025 | Compensation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the RXRX Form 144 disclose about the 100,000 shares?

The Form 144 discloses a proposed sale of 100,000 Class A shares tied to restricted stock vesting on 05/15/2025. The filing treats the shares as issuer compensation-related vesting.

Who reported recent Class A sales in the RXRX excerpt?

The excerpt lists sales reported by Christopher C. Gibson, showing multiple trades between 04/07/2026 and 06/18/2026, including a cumulative 340,440 shares row for $1,089,541.29.

Do the filings guarantee these 100,000 shares have been sold?

No. The Form 144 is a notice of an intended resale tied to vesting; it discloses intent and recent sales but does not by itself confirm completion of the proposed 100,000-share sale.

What transaction details are shown for recent RXRX trades?

The excerpt shows individual reported trades of 40,000 shares on several dates with per‑trade proceeds (e.g., $124,000, $144,400, $134,800). A cumulative entry records 340,440 shares for $1,089,541.29.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 05:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001856369
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RECURSION PHARMACEUTICALS, INC.
SEC File Number	001-40323
Address of Issuer	41S RIO GRANDE STREET SALT LAKE CITY UTAH 84101
Phone	(385) 269-0203
Name of Person for Whose Account the Securities are To Be Sold	Gibson Christopher
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	100000	366630.37	524677865	07/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	05/15/2025	Restricted Stock Vesting	Issuer			100000	05/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	04/07/2026	40000	124000.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	04/22/2026	40000	144400.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	05/07/2026	40000	134800.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	05/22/2026	40000	123200.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	06/05/2026	40000	144800.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	06/18/2026	340440	1089541.29

144: Remarks and Signature

Remarks
Date of Notice	07/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Christopher C. Gibson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)